Leading dentist Dr Sofina Ahmed shares how GLP-1 medications are creating visible and lasting changes to smiles ...

Ozempic, a popular drug for type 2 diabetes, has gained traction for its weight loss benefits, but it comes with potential ...

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Weight loss drugs can cause side effects including nausea, vomiting, diarrhoea, haemorrhoids and constipation, which can ...

Novo Nordisk has awarded a 50 million kroner ($7.6M) grant to the University of Copenhagen to develop less processed ...

The molecule is semaglutide, and it's sold under the name Ozempic for type 2 diabetes and Wegovy for weight ... They are ...

Ozempic, originally prescribed for type 2 diabetes, is now widely used off-label for weight loss, but rapid results can lead ...

A new oral weight loss pill shows results similar to Ozempic and Wegovy injections in the treatment of obesity.

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Lilly's weight-loss drug trial shows promising results, propelling stock up 14.36%. Goldman Sachs predicts potential $23.5B in sales by 2035.

Eli Lilly's new pill shows impressive results, matching Ozempic in lowering weight and blood sugar levels for diabetes ...

Eli Lilly stock rises more than 11% as weight loss pill orforglipron shows promising trial results, raising hopes for a ...